SCHEMBL6299971

SCHEMBL6299971

CCC(CC)CN1C(=O)CNCc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BMPR1B O00238 1/20 0.37
BMPR1A P36894 1/20 0.37
TGFBR1 P36897 1/20 0.37
ACVRL1 P37023 1/20 0.37
ACVR1 Q04771 1/20 0.37
LMNA P02545 3/20 0.37
GAA P10253 2/20 0.37
GFER P55789 1/20 0.37
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
POLB P06746 1/20 0.36
CHRM2 P08172 2/20 0.36
CHRM1 P11229 2/20 0.36
DRD3 P35462 2/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
DRD2 P14416 1/20 0.36
CHRM3 P20309 1/20 0.36
DRD4 P21917 1/20 0.36
SLC6A2 P23975 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6300407 0.87 LMNA (0.43) LMNAGAAGFERPRMT5WDR77
SCHEMBL6300286 0.85 ATAD2 (0.43) LMNAGAAGFERPOLBCHRM2
SCHEMBL6300067 0.75 HTR7 (0.40) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL6849564 0.75 CHRM2 (0.39) POLBCHRM2CHRM1DRD3CHRM4
SCHEMBL6302300 0.75 POLB (0.65) GAAPOLBCHRM2CHRM1DRD3
SCHEMBL21257673 0.74 HRH1 (0.56) LMNACHRM2CHRM1DRD3CHRM4
SCHEMBL7242958 0.73 ADRA2A (0.40) BMPR1BBMPR1ATGFBR1ACVRL1ACVR1
SCHEMBL3425056 0.73 NPSR1 (0.57) LMNAGAAMEN1KMT2A
SCHEMBL6300376 0.72 CHRM2 (0.52) GAAPOLBCHRM2CHRM1DRD3
SCHEMBL6768550 0.72 ALDH1A1 (0.54) LMNADRD3HTR1ASLC6A4CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6838455-B2 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds ATHENA NEUROSCIENCES, INC. (US) 2005-01-04 US disclosed
US-6774125-B2 TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. 2004-08-10 US disclosed
US-6696438-B2 AMYLOID PRECURSOR PROTEIN ANTAGONISTS, 3-((N'-(3-PYRIDINOYL)-L -ALANINYL)-AMINO-3-METHYL-4,5,6,7-TETRAHYDRO-2H-3-BENZAZEPIN-2-ONE, USED FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASES SUCH AS ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. 2004-02-24 US disclosed
US-6552013-B1 For therapy of Alzheimer's disease ELAN PHARMACEUTICALS, INC. 2003-04-22 US disclosed
US-6528505-B1 Treating Alzheimer's disease;5-(S)-(N'-(L-prolyl)-L-alaninyl)-amino-7-methyl-5,7-di hydro-6H- dibenz(b,d)azepin-one ELAN PHARMACEUTICALS, INC. 2003-03-04 US disclosed
US-6509331-B1 Bicyclic amides such as 5-('-(2S-hydroxy-3-methylbutyrl)-2S-aminopropyl)amino-7-methyl-5,7-dihydro -6H-dibenz(b,d)azepin-6-one ELAN PHARMACEUTICALS, INC. 2003-01-21 US disclosed